Junjie Zhang

14PUBLICATIONS
23CO-AUTHORS
Innate immunityCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 02, 2026
RAS P21 Protein Activator 3 finetunes Type I immunity by limiting HCK-mediated STAT4 phosphorylation.

|Jun 24, 2026
SUMOylation and ubiquitination reciprocally regulate SMCHD1 antiviral activity against herpes simplex virus 1.

|Mar 17, 2026
Triple-Cascade Responsive Pneumatic Nanomotor Enhance Cancer Immunotherapy by Oncolytic Virus-Triggered Pyroptosis.

Wen-Da Wang, Chi-Hui Yang, Wen-Tao Mo

|Nov 10, 2025
Human-specific activation of the DUX4-SLC34A2 axis by herpesviruses suppresses antiviral innate immunity.

Ming Gao, Xi Cheng, Chuchu Zhang

|Apr 10, 2025
Disrupting the OTUD4-USP7 deubiquitinase complex to suppress herpesvirus replication: a novel antiviral strategy.

Shaowei Wang, Xuezhang Tian, Yunhong Zhong

|Jul 22, 2024
Dual-Responsive Epigenetic Inhibitor Nanoprodrug Combined with Oncolytic Virus Synergistically Boost Cancer Immunotherapy by Igniting Gasdermin E-Mediated Pyroptosis.

Yuan-Yuan Wang, Jingting Wang, Shuo Wang

Pageof 3

Frequent Collaborators

4 joint publications

Pinghui Feng

4 joint publications

Zhijun Sun

2 joint publications

Ke Lan

2 joint publications

Hong-Bing Shu